Framingham, MA, United States of America

Lawrence Mortin


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lawrence Mortin

Introduction

Lawrence Mortin is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of biofilm infections. His work has led to advancements that can improve patient outcomes in critical care settings.

Latest Patents

Mortin holds a patent for "Daptomycin for the treatment of biofilm and catheter salvage." This invention focuses on the use of daptomycin for treating biofilm, especially in the context of central venous catheter salvage for infected catheters. The patent highlights that catheter salvage with daptomycin demonstrates rapid cidality, effectiveness against stationary phase bacteria, and the ability to penetrate and act within biofilms. The formulations and methods provided in this patent are essential for improving biofilm treatment and catheter salvage.

Career Highlights

Lawrence Mortin is associated with Cubist Pharmaceuticals, Incorporated, where he has been instrumental in developing innovative solutions for complex medical challenges. His work has been recognized for its potential to enhance the efficacy of treatments for patients with catheter-related infections.

Collaborations

Mortin has collaborated with notable colleagues, including Jeffrey Alder and Jared Silverman. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Lawrence Mortin's contributions to the field of medicine through his patent on daptomycin exemplify the impact of innovation in healthcare. His work continues to pave the way for improved treatment options for patients suffering from biofilm infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…